Phosphorylation of collapsin response mediator protein-2 disrupts neuronal maturation in a model of adult neurogenesis: Implications for neurodegenerative disorders

Molecular Neurodegeneration

Volumn 6, Issue 1, 2011, Pages

  Crews, Leslie ^a   Ruf, Rebecca ^a   Patrick, Christina ^a   Dumaop, Wilmar ^b   Trejo Morales, Margarita ^a   Achim, Cristian L ^c   Rockenstein, Edward ^a   Masliah, Eliezer ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CDK5; CRMP2; dpysl2; encephalitis; HIV; microtubules; neurite outgrowth; neurogenesis

Indexed keywords

COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; CYCLIN DEPENDENT KINASE 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MATURATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; ENCEPHALITIS; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCHEMISTRY; IN VITRO STUDY; MICROTUBULE; MOUSE; NERVE CELL; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

MUS MUSCULUS;

EID: 80053174893     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-6-67     Document Type: Article

References (61)

1. Staying connected: synapses in Alzheimer disease. Lee HG, Moreira PI, Zhu X, Smith MA, Perry G, Am J Pathol 2004 165 1461 1464 10.1016/S0002-9440(10) 63404-9 15509517 (Pubitemid 39435146)
2. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH, Grant I, Ann Neurol 1997 42 963 972 10.1002/ana.410420618 9403489 (Pubitemid 28008427)
3. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Kaul M, Garden GA, Lipton SA, Nature 2001 410 988 994 10.1038/35073667 11309629 (Pubitemid 32335850)
4. Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35/Cdk5 and p25/Cdk5. Liu F, Su Y, Li B, Zhou Y, Ryder J, Gonzalez-DeWhitt P, May PC, Ni B, FEBS Lett 2003 547 193 196 10.1016/S0014-5793(03)00714-2 12860412 (Pubitemid 36829404)
5. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH, Nature 1999 402 615 622 10.1038/45159 10604467 (Pubitemid 129516324)
6. Changes of tau profiles in brains of the hamsters infected with scrapie strains 263 K or 139 A possibly associated with the alteration of phosphate kinases. Wang GR, Shi S, Gao C, Zhang BY, Tian C, Dong CF, Zhou RM, Li XL, Chen C, Han J, Dong XP, BMC Infect Dis 2010 10 86 10.1186/1471-2334-10-86 20356412
7. Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain. Lee KY, Clark AW, Rosales JL, Chapman K, Fung T, Johnston RN, Neurosci Res 1999 34 21 29 10.1016/S0168-0102(99)00026-7 10413323 (Pubitemid 29245996)
8. Increased CDK5 Expression in HIV Encephalitis Contributes to Neurodegeneration via Tau Phosphorylation and Is Reversed with Roscovitine. Patrick C, Crews L, Desplats P, Dumaop W, Rockenstein E, Achim CL, Everall IP, Masliah E, Am J Pathol 2011 178 1646 1661 10.1016/j.ajpath.2010.12.033 21435449
9. Increased hippocampal neurogenesis in Alzheimer's disease. Jin K, Peel AL, Mao XO, Xie L, Cottrell BA, Henshall DC, Greenberg DA, Proc Natl Acad Sci USA 2004 101 343 347 10.1073/pnas.2634794100 14660786 (Pubitemid 38084252)
10. Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus. Boekhoorn K, Joels M, Lucassen PJ, Neurobiol Dis 2006 24 1 14 10.1016/j.nbd.2006.04.017 16814555 (Pubitemid 44416208)
11. Failure of neuronal maturation in Alzheimer disease dentate gyrus. Li B, Yamamori H, Tatebayashi Y, Shafit-Zagardo B, Tanimukai H, Chen S, Iqbal K, Grundke-Iqbal I, J Neuropathol Exp Neurol 2008 67 78 84 10.1097/nen. 0b013e318160c5db 18091557
12. Increased BMP6 levels in the brains of Alzheimer's disease patients and APP transgenic mice are accompanied by impaired neurogenesis. Crews L, Adame A, Patrick C, Delaney A, Pham E, Rockenstein E, Hansen L, Masliah E, J Neurosci 2010 30 12252 12262 10.1523/JNEUROSCI.1305-10.2010 20844121
13. HIV/gp120 Decreases Adult Neural Progenitor Cell Proliferation via Checkpoint Kinase-Mediated Cell-Cycle Withdrawal and G1 Arrest. Okamoto S, Kang YJ, Brechtel CW, Siviglia E, Russo R, Clemente A, Harrop A, McKercher S, Kaul M, Lipton SA, Cell Stem Cell 2007 1 230 236 10.1016/j.stem.2007.07.010 18371353 (Pubitemid 47215594)
14. HIV's double strike at the brain: neuronal toxicity and compromised neurogenesis. Kaul M, Front Biosci 2008 13 2484 2494 10.2741/2860 17981728 (Pubitemid 351599699)
15. Cdk5 regulates accurate maturation of newborn granule cells in the adult hippocampus. Jessberger S, Aigner S, Clemenson GD Jr, Toni N, Lie DC, Karalay O, Overall R, Kempermann G, Gage FH, PLoS Biol 2008 6 272 10.1371/journal.pbio. 0060272 18998770
16. Cdk5 is essential for adult hippocampal neurogenesis. Lagace DC, Benavides DR, Kansy JW, Mapelli M, Greengard P, Bibb JA, Eisch AJ, Proc Natl Acad Sci USA 2008 105 18567 18571 10.1073/pnas.0810137105 19017796
17. Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease. Crews L, Patrick C, Adame A, Rockenstein E, Masliah E, Cell Death Dis 2011 2 120 10.1038/cddis.2011.2 21368891
18. Cdk5 regulates the organization of Nestin and its association with p35. Sahlgren CM, Mikhailov A, Vaittinen S, Pallari HM, Kalimo H, Pant HC, Eriksson JE, Mol Cell Biol 2003 23 5090 5106 10.1128/MCB.23.14.5090-5106.2003 12832492 (Pubitemid 36793352)
19. Site-specific phosphorylation of synapsin I by mitogen-activated protein kinase and Cdk5 and its effects on physiological functions. Matsubara M, Kusubata M, Ishiguro K, Uchida T, Titani K, Taniguchi H, J Biol Chem 1996 271 21108 21113 10.1074/jbc.271.35.21108 8702879 (Pubitemid 26292961)
20. Increased CRMP2 phosphorylation is observed in Alzheimer's disease; does this tell us anything about disease development? Soutar MP, Thornhill P, Cole AR, Sutherland C, Curr Alzheimer Res 2009 6 269 278 10.2174/156720509788486572 19519308
21. Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression. Cole AR, Noble W, van Aalten L, Plattner F, Meimaridou R, Hogan D, Taylor M, LaFrancois J, Gunn-Moore F, Verkhratsky A, Oddo S, LaFerla F, Giese KP, Dineley KT, Duff K, Richardson JC, Yan SD, Hanger DP, Allan SM, Sutherland C, J Neurochem 2007 103 1132 1144 10.1111/j.1471-4159.2007.04829.x 17683481 (Pubitemid 47568734)
22. Collapsin response mediator protein-2 is associated with neurofibrillary tangles in Alzheimer's disease. Yoshida H, Watanabe A, Ihara Y, J Biol Chem 1998 273 9761 9768 10.1074/jbc.273.16.9761 9545313 (Pubitemid 28183069)
23. Synaptic proteins linked to HIV-1 infection and immunoproteasome induction: proteomic analysis of human synaptosomes. Gelman BB, Nguyen TP, J Neuroimmune Pharmacol 2010 5 92 102 10.1007/s11481-009-9168-0 19693676
24. First evidence of overlaps between HIV-Associated Dementia (HAD) and non-viral neurodegenerative diseases: proteomic analysis of the frontal cortex from HIV+ patients with and without dementia. Zhou L, Diefenbach E, Crossett B, Tran SL, Ng T, Rizos H, Rua R, Wang B, Kapur A, Gandhi K, Brew BJ, Saksena NK, Mol Neurodegener 2010 5 27 10.1186/1750-1326-5-27 20573273
25. Distinct priming kinases contribute to differential regulation of collapsin response mediator proteins by glycogen synthase kinase-3 in vivo. Cole AR, Causeret F, Yadirgi G, Hastie CJ, McLauchlan H, McManus EJ, Hernandez F, Eickholt BJ, Nikolic M, Sutherland C, J Biol Chem 2006 281 16591 16598 10.1074/jbc.M513344200 16611631
26. Semaphorin3A signaling mediated by Fyn-dependent tyrosine phosphorylation of collapsin response mediator protein 2 at tyrosine 32. Uchida Y, Ohshima T, Yamashita N, Ogawara M, Sasaki Y, Nakamura F, Goshima Y, J Biol Chem 2009 284 27393 27401 10.1074/jbc.M109.000240 19652227
27. CRMP family protein: Novel targets for CDK5 that regulate axon guidance, synapse maturation, and cell migration. Goshima Y, Sasaki Y, Uchida Y, Yamashita M, Nakamura F, Cyclin dependent kinase 5 (Cdk5) New York: Springer, Ip NY, Tsai LH, 2008 9 24
28. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3 phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease. Uchida Y, Ohshima T, Sasaki Y, Suzuki H, Yanai S, Yamashita N, Nakamura F, Takei K, Ihara Y, Mikoshiba K, Kolattukudy P, Honnorat J, Goshima Y, Genes Cells 2005 10 165 179 15676027 (Pubitemid 40287519)
29. Relative resistance of Cdk5-phosphorylated CRMP2 to dephosphorylation. Cole AR, Soutar MP, Rembutsu M, van Aalten L, Hastie CJ, McLauchlan H, Peggie M, Balastik M, Lu KP, Sutherland C, J Biol Chem 2008 283 18227 18237 10.1074/jbc.M801645200 18460467
30. CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Fukata Y, Itoh TJ, Kimura T, Menager C, Nishimura T, Shiromizu T, Watanabe H, Inagaki N, Iwamatsu A, Hotani H, Kaibuchi K, Nat Cell Biol 2002 4 583 591 12134159
31. Activation of cyclin-dependent kinase 5 by calpains contributes to human immunodeficiency virus-induced neurotoxicity. Wang Y, White MG, Akay C, Chodroff RA, Robinson J, Lindl KA, Dichter MA, Qian Y, Mao Z, Kolson DL, Jordan-Sciutto KL, J Neurochem 2007 103 439 455 10.1111/j.1471-4159.2007.04746.x 17897354 (Pubitemid 47498010)
32. A Jekyll and Hyde kinase: roles for Cdk5 in brain development and disease. Cruz JC, Tsai LH, Curr Opin Neurobiol 2004 14 390 394 10.1016/j.conb.2004.05.002 15194121 (Pubitemid 38759871)
33. Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: a novel excitoprotective mechanism involving modulation of tau phosphorylation. Han P, Dou F, Li F, Zhang X, Zhang YW, Zheng H, Lipton SA, Xu H, Liao FF, J Neurosci 2005 25 11542 11552 10.1523/JNEUROSCI.3831-05.2005 16354912 (Pubitemid 43098447)
34. Neurofibrillary tangle-associated collapsin response mediator protein-2 (CRMP-2) is highly phosphorylated on Thr-509, Ser-518, and Ser-522. Gu Y, Hamajima N, Ihara Y, Biochemistry 2000 39 4267 4275 10.1021/bi992323h 10757975 (Pubitemid 30212642)
35. The -amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. Petratos S, Li QX, George AJ, Hou X, Kerr ML, Unabia SE, Hatzinisiriou I, Maksel D, Aguilar MI, Small DH, Brain 2008 131 90 108 10.1093/brain/awm181 18000012 (Pubitemid 351197602)
36. Rescue of adult hippocampal neurogenesis in a mouse model of HIV neurologic disease. Lee MH, Wang T, Jang MH, Steiner J, Haughey N, Ming GL, Song H, Nath A, Venkatesan A, Neurobiol Dis 2011 41 678 687 10.1016/j.nbd.2010.12. 002 21146610
37. Adult hippocampal neurogenesis: regulation by HIV and drugs of abuse. Venkatesan A, Nath A, Ming GL, Song H, Cell Mol Life Sci 2007 64 2120 2132 10.1007/s00018-007-7063-5 17530169 (Pubitemid 350092418)
38. Collapsin response mediator proteins (CRMPs): involvement in nervous system development and adult neurodegenerative disorders. Charrier E, Reibel S, Rogemond V, Aguera M, Thomasset N, Honnorat J, Mol Neurobiol 2003 28 51 64 10.1385/MN:28:1:51 14514985 (Pubitemid 38156435)
39. Processing and nuclear localization of CRMP2 during brain development induce neurite outgrowth inhibition. Rogemond V, Auger C, Giraudon P, Becchi M, Auvergnon N, Belin MF, Honnorat J, Moradi-Ameli M, J Biol Chem 2008 283 14751 14761 10.1074/jbc.M708480200 18332147
40. Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Goshima Y, Nakamura F, Strittmatter P, Strittmatter SM, Nature 1995 376 509 514 10.1038/376509a0 7637782
41. Brain CRMP forms heterotetramers similar to liver dihydropyrimidinase. Wang LH, Strittmatter SM, J Neurochem 1997 69 2261 2269 9375656 (Pubitemid 27495410)
42. GSK-3 phosphorylation of the Alzheimer epitope within collapsin response mediator proteins regulates axon elongation in primary neurons. Cole AR, Knebel A, Morrice NA, Robertson LA, Irving AJ, Connolly CN, Sutherland C, J Biol Chem 2004 279 50176 50180 10.1074/jbc.C400412200 15466863 (Pubitemid 39577830)
43. Phosphorylation of collapsin response mediator protein-2 by Rho-kinase. Evidence for two separate signaling pathways for growth cone collapse. Arimura N, Inagaki N, Chihara K, Menager C, Nakamura N, Amano M, Iwamatsu A, Goshima Y, Kaibuchi K, J Biol Chem 2000 275 23973 23980 10.1074/jbc.M001032200 10818093 (Pubitemid 30624686)
44. Role of CRMP-2 in neuronal polarity. Arimura N, Menager C, Fukata Y, Kaibuchi K, J Neurobiol 2004 58 34 47 10.1002/neu.10269 14598368 (Pubitemid 37543336)
45. Interaction of neuronal Cdc2-like protein kinase with microtubule-associated protein tau. Sobue K, Agarwal-Mawal A, Li W, Sun W, Miura Y, Paudel HK, J Biol Chem 2000 275 16673 16680 10.1074/jbc.M000784200 10749861 (Pubitemid 30398896)
46. Microtubule association of the neuronal p35 activator of Cdk5. Hou Z, Li Q, He L, Lim HY, Fu X, Cheung NS, Qi DX, Qi RZ, J Biol Chem 2007 282 18666 18670 10.1074/jbc.C700052200 17491008 (Pubitemid 47100129)
47. Stabilization of the cyclin-dependent kinase 5 activator, p35, by paclitaxel decreases -amyloid toxicity in cortical neurons. Li G, Faibushevich A, Turunen BJ, Yoon SO, Georg G, Michaelis ML, Dobrowsky RT, J Neurochem 2003 84 347 362 10.1046/j.1471-4159.2003.01526.x 12558997 (Pubitemid 36182276)
48. Evidence that collapsin response mediator protein-2 is involved in the dynamics of microtubules. Gu Y, Ihara Y, J Biol Chem 2000 275 17917 17920 10.1074/jbc.C000179200 10770920 (Pubitemid 30414732)
49. Differential properties of adult rat and mouse brain-derived neural stem/progenitor cells. Ray J, Gage FH, Mol Cell Neurosci 2006 31 560 573 10.1016/j.mcn.2005.11.010 16426857 (Pubitemid 43358027)
50. Fluorescence Procedures for the Actin and Tubulin Cytoskeleton in Fixed Cells. Desai A, Mitchison T, http://mitchison.med.harvard.edu/protocols/gen1. html Accessed 8/25/2011.
51. Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images. Meijering E, Jacob M, Sarria JC, Steiner P, Hirling H, Unser M, Cytometry A 2004 58 167 176 15057970 (Pubitemid 38509178)
52. Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux. Marongiu R, Spencer B, Crews L, Adame A, Patrick C, Trejo M, Dallapiccola B, Valente EM, Masliah E, J Neurochem 2009 108 1561 1574 10.1111/j.1471-4159.2009.05932.x 19166511
53. Early formation of mature amyloid-b proteins deposits in a mutant APP transgenic model depends on levels of Ab1-42. Rockenstein E, Mallory M, Mante M, Sisk A, Masliah E, J neurosci Res 2001 66 573 582 10.1002/jnr.1247 11746377 (Pubitemid 33032326)
54. Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. Achim CL, Heyes MP, Wiley CA, J Clin Invest 1993 91 2769 2775 10.1172/JCI116518 8514884 (Pubitemid 23182534)
55. Spectrum of human immunodeficiency virus-associated neocortical damage. Masliah E, Achim C, Ge N, DeTeresa R, Terry R, Wiley C, AnnNeurol 1992 32 321 329
56. Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis [Erratum appeared in J Neuroimmunol 2005, 162:197]. Masliah E, Roberts ES, Langford D, Everall I, Crews L, Adame A, Rockenstein E, Fox HS, J Neuroimmunol 2004 157 163 175 10.1016/j.jneuroim.2004.08.026 15579294 (Pubitemid 39576651)
57. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Toggas S, Masliah E, Rockenstein E, Mucke L, Nature 1994 367 188 193 10.1038/367188a0 8114918 (Pubitemid 24031702)
58. Age-related behavioural deficits in transgenic mice expressing the HIV-1 coat protein gp120. D'Hooge R, Franck F, Mucke L, De Deyn PP, Eur J Neurosci 1999 11 4398 4402 10.1046/j.1460-9568.1999.00857.x 10594667 (Pubitemid 30009272)
59. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, Brady RO, Martin LJ, Kulkarni AB, Proc Natl Acad Sci USA 1996 93 11173 11178 10.1073/pnas.93.20.11173 8855328 (Pubitemid 26333137)
60. A1-42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD. Masliah E, Alford M, Adame A, Rockenstein E, Galasko D, Salmon D, Hansen LA, Thal LJ, Neurology 2003 61 206 211 12874400 (Pubitemid 36875302)
61. Dopaminergic loss and inclusion body formation in -synuclein mice: Implications for neurodegenerative disorders. Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara, Sisk A, Mucke L, Science 2000 287 1265 1269 10.1126/science.287.5456.1265 10678833 (Pubitemid 30112148)